Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000761920 | SCV000725063 | likely benign | not provided | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315928 | SCV000848119 | likely benign | Inborn genetic diseases | 2022-06-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000761920 | SCV000892145 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | CHD2: BP4, BS2 |
Labcorp Genetics |
RCV001082364 | SCV001001205 | benign | Developmental and epileptic encephalopathy 94 | 2025-01-15 | criteria provided, single submitter | clinical testing |